BIOGEN INC. — Director's Dealing 2022

Dec 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2022-11-14

Reporting Person: Gregory Ginger (EVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-14	Common Stock	S	5610	$300.11	Disposed	5711.0168	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2022.